A trial to study the effect of kangaroo mother care (KMC) on duration of phototherapy in neonatal jaundice

Completed

• Conditions: hemodynamically stable neonates requiring phototherapy for neonatal jaundice

• Registration Number: CTRI/2017/07/009006
• Lead Sponsor: Chacha Nehru Bal Chikitsalya

Brief Summary

Kangaroo Mother Care [KMC] consists of skin to skin contact between mother and infant in a vertical position (kangaroo position). It helps in preventing hypothermia, stabilizes physiological parameters, significantly increases breast milk production, improves weight gain and helps in early discharge. Phototherapy is the mainstay of treating hyperbilirubinemia in neonates. During phototherapy the neonate is kept naked under the light in a cot and is taken out only for breastfeeding. Hence during phototherapy there is lack of contact between mother and baby which deprives the baby from the benefits of KMC. This study proposes to analyze the effect of intermittent KMC in neonatal jaundice. By giving phototherapy along with KMC in one group and only photoherapy in another, this study will show if KMC is effective in reducing the duration of phototherapy required in neonatal jaundice.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-10-16
• Last Update Posted: 2017-07-07

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

1.hemodynamically stable neonates admitted in NICU 2.gestational age 30 to 40 weeks 3.weighing more than 1000 but less than 2000 gram 4.requiring phototherapy as per AAP guidelines 2004 for newborns more than 35 weeks of gestational age and as per criteria laid down by Maisels et al ( Jour Perinatol 2012)for newborns less than 35 weeks of gestational age.

Exclusion Criteria

• 1.Patient with major congenital malformations 2.Unstable patients on CPAP (Continuous Positive Airway Pressure) or on ventilator or requiring ionotropes.
• 3.Patient requiring exchange transfusion as per AAP guidelines 2004 for newborns more than 35 weeks of gestational age and as per criteria laid down by Maisels et al ( Jour Perinatol 2012)for newborns less than 35 weeks of gestational age .
• 4.Patient presenting with jaundice in first 24 hours of life with rate of rise of bilirubin > 5 mg/ dl/day.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
duration of phototherapy required	duration of phototherapy required as per AAP guidelines 2004 for newborns more than 35 weeks of gestational age and as per criteria laid down by Maisels et al ( Jour Perinatol 2012)for newborns less than 35 weeks of gestational age

Secondary Outcome Measures

Name	Time	Method
rate of fall in serum bilirubin	rate of fall in serum bilirubin during phototherapy required as per AAP guidelines 2004 for newborns more than 35 weeks of gestational age and as per criteria laid down by Maisels et al ( Jour Perinatol 2012)for newborns less than 35 weeks of gestational age
weight gain per day	weight gain per day during phototherapy required as per AAP guidelines 2004 for newborns more than 35 weeks of gestational age and as per criteria laid down by Maisels et al ( Jour Perinatol 2012)for newborns less than 35 weeks of gestational age
temperature maintenance	temperature is measured eight hourly or before , duringand after KMC till phototherapy is required as per AAP guidelines 2004 for newborns more than 35 weeks of gestational age and as per criteria laid down by Maisels et al ( Jour Perinatol 2012)for newborns less than 35 weeks of gestational age
hospital stay	discharge of patient from NICU

Trial Locations

Locations (1)

Chacha Nehru Bal Chikitsalaya; 🇮🇳 Delhi, DELHI, India

Chacha Nehru Bal Chikitsalaya

🇮🇳Delhi, DELHI, India

Dr Apoorva Chandil

Principal investigator

8375846683

apoorvachandil@gmail.com